Quercetin Simultaneously Inhibited Cytochrome P450 and P-Glycoprotein to Improve the Pharmacokinetics of Osthole in Rat Plasma-Reference-Cited by-同舟云学术

Quercetin Simultaneously Inhibited Cytochrome P450 and P-Glycoprotein to Improve the Pharmacokinetics of Osthole in Rat Plasma

Published:2023-11-16 Issue: Volume: Page:
ISSN:1981-528X
Container-title:Revista Brasileira de Farmacognosia
language:en
Short-container-title:Rev. Bras. Farmacogn.

Author:

Huang Mingjun^ORCID,Wu Fanchang^ORCID,Zuo Xue^ORCID,Liu Jinman^ORCID,Yu Wenqian^ORCID,Xie Ruiye^ORCID,Liu Guoqing^ORCID,Tan Qiwen^ORCID,Wang Qi^ORCID,Liang Yong^ORCID

Funder

National Natural Science Foundation of China

Guangzhou Municipal Science and Technology Project

Publisher

Springer Science and Business Media LLC

Subject

General Pharmacology, Toxicology and Pharmaceutics

Link

https://link.springer.com/content/pdf/10.1007/s43450-023-00487-3.pdf

Reference30 articles.

1. Ashour ML, Youssef FS, Gad HA, Wink M (2017) Inhibition of cytochrome P450 (CYP3A4) activity by extracts from 57 plants used in traditional Chinese medicine (TCM). Pharmacogn Mag 13:300–308. https://doi.org/10.4103/0973-1296.204561

2. Benet LZ, Cummins CL, Wu CY (2004) Unmasking the dynamic interplay between efflux transporters and metabolic enzymes. Int J Pharm 277:3–9. https://doi.org/10.1016/j.ijpharm.2002.12.002

3. Borska S, Sopel M, Chmielewska M, Zabel M, Dziegiel P (2010) Quercetin as a potential modulator of P-glycoprotein expression and function in cells of human pancreatic carcinoma line resistant to daunorubicin. Molecules 15:857–870. https://doi.org/10.3390/molecules15020857

4. Cai H, Luo Y, Yan X, Ding P, Huang Y, Fang S, Zhang R, Chen Y, Guo Z, Fang J, Wang Q, Xu J (2018) The mechanisms of Bushen-Yizhi formula as a therapeutic agent against Alzheimer’s disease. Sci Rep 8:3104. https://doi.org/10.1038/s41598-018-21468-w

5. Chen J, Liu J, Huang Y, Li R, Ma C, Zhang B, Wu F, Yu W, Zuo X, Liang Y, Wang Q (2021) Insights into oral bioavailability enhancement of therapeutic herbal constituents by cytochrome P450 3A inhibition. Drug Metab Rev 53:491–507. https://doi.org/10.1080/03602532.2021.1917598